| Authors: |
Rizzo A; Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. angela.rizzo@ifo.it., Iachettini S; Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. sara.iachettini@gmail.com., Zizza P; Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. zizza@ifo.it., Cingolani C; Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. chiara.cingolani@hotmail.com., Porru M; Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. manuelaporru@tiscali.it., Artuso S; Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. artusem@inwind.it., Stevens M; School of Pharmacy, University of Nottingham, Nottingham, NG7 2RD, UK. Malcolm.Stevens@nottingham.ac.uk., Hummersone M; Pharminox Ltd, Biocity, Pennyfoot St, Nottingham, NG1 1GF, UK. marc.hummersone@pharminox.com., Biroccio A; Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. biroccio@ifo.it., Salvati E; Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. erica.salvati@gmail.com., Leonetti C; Experimental Chemotherapy Laboratory, Regina Elena National Cancer Institute, Nottingham, NG7 2RD, UK. leonetti@ifo.it. |